Suppr超能文献

桂枝茯苓丸(keishi-bukuryo-gan)对人子宫肌瘤的药物治疗作用。

Pharmacotherapeutic effects of kuei-chih-fu-ling-wan (keishi-bukuryo-gan) on human uterine myomas.

作者信息

Sakamoto S, Yoshino H, Shirahata Y, Shimodairo K, Okamoto R

机构信息

Medical Research Institute, Tokyo Medical and Dental University, Japan.

出版信息

Am J Chin Med. 1992;20(3-4):313-7. doi: 10.1142/S0192415X92000333.

Abstract

Kuei-chih-fu-ling-wan (Keishi-bukuryo-gan; KBG), a traditional Chinese herbal remedy contains five components: bark of Cinnamomum cassia Bl. (Lauraceae), root of Paeonia lactiflora Pall. (Paeoniaceae), seed of Prunus persica Batsch. or P. persiba Batsch.var.davidiana Maxim. (Rosaceae), carpophores of Poria cocos Wolf. (Polyporaceae), and root bark of Paeonia suffruticosa Andr. (Paeoniaceae). This prescription has been frequently used in the treatment of gynecological disorders such as hypermenorrhea, dysmenorrhea and sterility. We previously reported that KBG might act as a LH-RH antagonist and a weak anti-estrogen on the uterine DNA synthesis in immature rats. In the present study, we investigated the effects of KBG on 110 premenopausal patients with uterine myomas. Clinical symptoms of hypermenorrhea and dysmenorrhea were improved in more than 90% of the cases with shrinking of uterine myomas in roughly 60% of the cases.

摘要

桂枝茯苓丸(Keishi-bukuryo-gan;KBG)是一种传统的中药方剂,包含五种成分:肉桂(樟科)、白芍(芍药科)、桃仁(蔷薇科)、茯苓(多孔菌科)和牡丹皮(芍药科)。该方剂常用于治疗妇科疾病,如月经过多、痛经和不孕。我们之前报道过,KBG可能作为促黄体生成素释放激素(LH-RH)拮抗剂和弱抗雌激素,对未成熟大鼠子宫DNA合成产生作用。在本研究中,我们调查了KBG对110例绝经前子宫肌瘤患者的影响。超过90%的病例中月经过多和痛经的临床症状得到改善,约60%的病例子宫肌瘤缩小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验